Nasal instillation of gpMBP can exacerbate murine EAE: Effect of mucosal priming is an age-dependent phenomenon

Journal of Autoimmunity

Volumn 22, Issue 1, 2004, Pages 13-20

  Melo, Marco E F ^a,b   Stevens, David B ^a,c   Sercarz, Eli E ^a,d   Gabaglia, Claudia Raja ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

EAE; gpMBP; Lymphocytes; Mice; Th2

Indexed keywords

MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; EVALUATION; GENETIC ANALYSIS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0346728707     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2003.09.005     Document Type: Article

References (35)

1. Hoyne G.F., Callow M.G., Kuhlman J., Thomas W.R. T-cell lymphokine response to orally administered proteins during priming and unresponsiveness. Immunology. 78:1993;534-540.
2. Blanas E., Carbone F.R., Allison J., Miller J.F., Heath W.R. Induction of autoimmune diabetes by oral administration of autoantigen. Science. 274:1996;1707-1709.
3. Xiao B.G., Link H. Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases. Clin Immunol Immunopathol. 85:1997;119-128.
4. Weiner H.L., Friedman A., Miller A., Khoury S.J., al-Sabbagh A., Santos L., et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 12:1994;809-837.
5. MacDonald T.T. T cell immunity to oral allergens. Curr Opin Immunol. 10:1998;620-627.
6. Dick A.D., Cheng Y.F., McKinnon A., Liversidge J., Forrester J.V. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol. 77:1993;171-175.
7. Faria A.M., Garcia G., Rios M.J., Michalaros C.L., Vaz N.M. Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-38-week-old mice. The effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology. 78:1993;147-151.
8. Melo M.E., Goldschmidt T.J., Bhardwaj V., Ho L., Miller A., Sercarz E. Immune deviation during the induction of tolerance by way of nasal installation: nasal installation itself can induce Th-2 responses and exacerbation of disease. Ann N Y Acad Sci. 778:1996;408-411.
9. Miller A., Lider O., Abramsky O., Weiner H.L. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol. 24:1994;1026-1032.
10. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., et al. Myelin basic protein-specific T helper 2 (Th2) cells causeexperimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med. 186:1997;307-312.
11. Diebler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mamalian species. Prep Biochem Biotechnol. 2:1972;139-165.
12. Metzler B., Wraith D.C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol. 5:1993;1159-1165.
13. Taguchi T., McGhee J.R., Coffman R.L., Beagley K.W., Eldridge J.H., Takatsu K., et al. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods. 128:1990;65-73.
14. Xu L.Y., Huang Y.M., Yang J.S., Van Der Meide P.H., Link H., Xiao B.G. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4. Clin Exp Immunol. 120:2000;526-531.
15. Quinn A., Melo M., Ethell D., Sercarz E.E. Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-A(g7)-expressing mouse strains. Int Immunol. 13:2001;1321-1333.
16. Hoyne G.F., Askonas B.A., Hetzel C., Thomas W.R., Lamb J.R. Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol. 8:1996;335-342.
17. Melo M.E., Gabaglia C.R., Moudgil K.D., Sercarz E.E., Quinn A. Strain-dependent effect of nasal instillation of antigen on the immune response in mice. Isr Med Assoc J. 4:2002;902-907.
18. Miller M.L., Cowdery J.S., Laskin C.A., Curtin M.F. Jr, Steinberg A.D. Heterogeneity of oral tolerance defects in autoimmune mice. Clin Immunol Immunopathol. 31:1984;231-240.
19. Peng H.J., Turner M.W., Strobel S. Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells. Pediatr Res. 26:1989;486-490.
20. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
21. Singh R.R., Hahn B.H., Sercarz E.E. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J Exp Med. 183:1996;1613-1621.
22. Hu W., Hasan A., Wilson A., Stanford M.R., Li-Yang Y., Todryk S., et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol. 28:1998;2444-2455.
23. Phipps P.A., Stanford M.R., Sun J.B., Xiao B.G., Holmgren J., Shinnick T., et al. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur J Immunol. 33:2003;224-232.
24. Hanninen A., Braakhuis A., Heath W.R., Harrison L.C. Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes. 50:2001;771-775.
25. Hanninen A., Martinez N.R., Davey G.M., Heath W.R., Harrison L.C. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J Clin Invest. 109:2002;261-267.
26. Martinez N.R., Augstein P., Moustakas A.K., Papadopoulos G.K., Gregori S., Adorini L., et al. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest. 111:2003;1365-1371.
27. Miller A., Lider O., al-Sabbagh A., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. J Neuroimmunol. 39:1992;243-250.
28. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
29. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 182:1995;75-85.
30. Tuohy V.K., Yu M., Yin L., Kawczak J.A., Kinkel R.P. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med. 189:1999;1033-1042.
31. Wildbaum G., Netzer N., Karin N. Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest. 110:2002;701-710.
32. Tian J., Olcott A.P., Kaufman D.L. Antigen-based immunotherapy drives the precocious development of autoimmunity. J Immunol. 169:2002;6564-6569.
33. Simitsek P.D., Campbell D.G., Lanzavecchia A., Fairweather N., Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med. 181:1995;1957-1963.
34. Manca F., Kunkl A., Fenoglio D., Fowler A., Sercarz E., Celada F. Constraints in T-B cooperation related to epitope topology on E. coli beta-galactosidase. I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants. Eur J Immunol. 15:1985;345-350.
35. Benichou G., Fedoseyeva E., Olson C.A., Geysen H.M., McMillan M., Sercarz E.E. Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant. Int Immunol. 6:1994;131-138.